Dolby Laboratories, Inc. Sales-type Lease, Unguaranteed Residual Asset
Dolby Laboratories, Inc. (DLB) had Sales-type Lease, Unguaranteed Residual Asset of $600.00 thousand as of 2026-06-26, per its 10-Q filed 2026-07-30.
Financial Statements › Notes › Leases › Sales-Type Lease, Net Investment in Lease, before Allowance for Credit Loss
us-gaap:SalesTypeLeaseUnguaranteedResidualAsset · last filed 2026-07-30
- 2026-06-26: Sales-type Lease, Unguaranteed Residual Asset $600.00K.
- 2026-03-27: Sales-type Lease, Unguaranteed Residual Asset $500.00K.
- 2025-12-26: Sales-type Lease, Unguaranteed Residual Asset $500.00K.
- 2025-09-26: Sales-type Lease, Unguaranteed Residual Asset $500.00K.
| Period end | Sales-type Lease, Unguaranteed Residual Asset |
|---|---|
| 2026-06-26 | $600.00K 10-Q · filed 2026-07-30 |
| 2026-03-27 | $500.00K 10-Q · filed 2026-04-30 |
| 2025-12-26 | $500.00K 10-Q · filed 2026-01-29 |
| 2025-09-26 | $500.00K 10-Q · filed 2026-07-30 |
| 2025-06-27 | $500.00K 10-Q · filed 2025-07-31 |
| 2025-03-28 | $600.00K 10-Q · filed 2025-05-01 |
| 2024-12-27 | $500.00K 10-Q · filed 2025-01-30 |
| 2024-09-27 | $900.00K 10-K · filed 2025-11-18 |
| 2024-06-28 | $900.00K 10-Q · filed 2024-08-07 |
| 2024-03-29 | $900.00K 10-Q · filed 2024-05-02 |
| 2023-12-29 | $1.00M 10-Q · filed 2024-02-02 |
| 2023-09-29 | $1.00M 10-K · filed 2024-11-19 |
| 2023-06-30 | $1.00M 10-Q · filed 2023-08-03 |
| 2023-03-31 | $1.00M 10-Q · filed 2023-05-05 |
| 2022-12-30 | $1.00M 10-Q · filed 2023-02-02 |
| 2022-09-30 | $1.10M 10-K · filed 2023-11-17 |
| 2021-12-31 | $800.00K 10-Q · filed 2022-02-04 |
| 2021-09-24 | $800.00K 10-K · filed 2022-11-18 |
| 2021-06-25 | $800.00K 10-Q · filed 2021-07-29 |
| 2021-03-26 | $800.00K 10-Q · filed 2021-05-04 |
| 2020-12-25 | $700.00K 10-Q · filed 2021-01-29 |
| 2020-09-25 | $700.00K 10-K · filed 2021-11-17 |
| 2020-06-26 | $700.00K 10-Q · filed 2020-08-03 |
| 2020-03-27 | $700.00K 10-Q · filed 2020-05-04 |
| 2019-12-27 | $700.00K 10-Q · filed 2020-01-29 |